Biggest News Aggregation in the World
📰 Lymph Node News

Page 11 - Lymph Node News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Lymph Node. Real-time updates on events, politics, business and more.

Study sheds light on how melanoma primes nearby lymph nodes for tumor metastases

Melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases, according to a new study by Weill Cornell Medicine investigators.
David Lyden Stavross Niarchos Emily Henderson Spanish National Cancer Research Center Metastasis Laboratory Ira Drukier Institute For Children Health

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.
South Africa United States Yale University Coronavirus Disease Covid 19 Ars Cov 2 B Cell

International collaboration secures €1M grant to investigate new treatment target for lymphoma

An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.
New York United States Memorial Sloan Kettering Cancer Center United Kingdom City Of Dana Farber Cancer Institute

Study proves safety and effectiveness of novel radionuclide therapy for neuroendocrine neoplasms

A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients.
National University Of Singapore Singapore General Jingjing Zhang Richardp Baum Emily Henderson International Centers For Precision Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science